Retrograde bladder filling after robotic-assisted endometrial cancer staging

Abstract

Objectives: To assess the utility of bladder backfill voiding trials in reducing the time to void after robotic-assisted endometrial cancer staging procedures Methods: All patients undergoing robotic staging for endometrial cancer from April 1, 2017 to April 1, 2019 at a tertiary referral center were identified and included in the cohort for analysis. Patients prior to April 1, 2018 were managed by Foley catheter removal in the OR at the conclusion of surgery. All patients after April 1, 2018 underwent a retrograde bladder filling with 300 mL of 0.9% NaCl (NS) with immediate Foley removal and subsequent voiding trial. A successful voiding trial entails voiding ≥200 mL with Results: During the study period, 96 patients from a single provider underwent robotic-assisted endometrial cancer staging. Forty-four patients underwent standard Foley removal in the OR at the conclusion of the surgery from April 1, 2017 to March 30, 2018. Beginning April 1, 2018 until April 1, 2019, 52 patients had retrograde bladder filling with 300 mL of NS with immediate Foley removal and subsequent voiding trial. The median time to void was 166 minutes following standard Foley removal protocol compared to 32 minutes in the retrograde backfill cohort (p Download : Download high-res image (161KB) Download : Download full-size image Conclusions: Bladder backfill voiding trial is associated with reduced time to void following robotic-assisted staging for endometrial cancer. The lack of difference in time to discharge is likely due to other criterion required for same-day discharge. This serves an impetus to address other means to expedite same-day discharge.